Related Experiment Video
Updated: May 10, 2025
05:11
Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
791
Current Clinical Trials for Alcohol-Associated Hepatitis
Elias D Rady1, Ahmad Anouti1, Mack C Mitchell1
1Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas.
The American Journal of Pathology
|April 20, 2025
Summary
Alcohol-associated hepatitis (AH) treatments are evolving beyond steroids. Emerging therapies target key disease mechanisms, but clinical trials face challenges in patient recruitment and design.
Area of Science:
- Hepatology
- Gastroenterology
- Translational Medicine
Background:
- Alcohol-associated hepatitis (AH) is a severe liver disease with high mortality.
- Current treatments like glucocorticoids have limited efficacy and side effects.
- Liver transplantation is an option for non-responders but is not widely accessible.
Purpose of the Study:
- To review the current pharmacologic treatments for AH.
- To highlight emerging therapies targeting novel pathophysiologic pathways.
- To discuss challenges in clinical trials for AH.
Main Methods:
- Literature review of current and emerging AH pharmacotherapies.
- Analysis of recent advances in understanding AH pathophysiology.
- Assessment of clinical trial designs and challenges in AH research.
Main Results:
- Glucocorticoids remain a primary, though limited, treatment for AH.
- New therapies target the gut-liver axis, inflammation, and oxidative stress.
- Clinical trials show promise but struggle with patient recruitment and standardization.
Conclusions:
- Innovative treatments for AH are under development, offering new hope.
- Addressing clinical trial challenges is crucial for advancing AH pharmacotherapy.
- Further research is needed to improve outcomes for patients with AH.
Related Concept Videos
01:11Clinical Trials: Overview
2.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.4K
01:16Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
01:30Enzyme Inhibition
77.4K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
77.4K
01:27CNS Depressants: Alcohol and Nicotine
152
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
152